BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27203791)

  • 1. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
    Trautmann F; Meier F; Seidler A; Schmitt J
    Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
    Schmitt J; Seidler A; Heinisch G; Sebastian G
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic skin cancer screening in Northern Germany.
    Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
    J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
    Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient management of patients with skin cancer in Germany: an analysis of the nationwide DRG-statistic 2005-2006.
    Stang A; Stausberg J
    Br J Dermatol; 2009 Nov; 161 Suppl 3():99-106. PubMed ID: 19775365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
    Katalinic A; Eisemann N; Waldmann A
    Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin cancer mortality in Germany before and after the post-communist transition.
    Stang A; Lampert T; Uhlemann T; Trocchi P
    Int J Dermatol; 2009 Apr; 48(4):363-70. PubMed ID: 19335420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
    Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
    Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-Year Follow-Up Study of Subjects Recruited in a Health Campaign for the Early Diagnosis of Cutaneous Melanoma: Suggestions for the Screening Timetable.
    Cristofolini M; Boi S; Cattoni D; Sicher MC; Decarli A; Micciolo R
    Dermatology; 2015; 231(4):345-52. PubMed ID: 26278413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
    Lee MS; Lin RY; Chang YT; Lai MS
    Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of skin cancer screening programmes.
    Choudhury K; Volkmer B; Greinert R; Christophers E; Breitbart EW
    Br J Dermatol; 2012 Aug; 167 Suppl 2():94-8. PubMed ID: 22881593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
    Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
    Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating prevalence and incidence of skin cancer in Germany.
    Krensel M; Petersen J; Mohr P; Weishaupt C; Augustin J; Schäfer I
    J Dtsch Dermatol Ges; 2019 Dec; 17(12):1239-1249. PubMed ID: 31885171
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.